Clinical Trials for Refractory Histiocytic and Dendritic Cell Neoplasm

Find clinical trials for refractory histiocytic and dendritic cell neoplasm. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

NCT ID: NCT04640779

This clinical trial is studying a combination of two medications, low-dose selinexor and choline salicylate, to find out their safety and the best dose to use for treating patients with certain typ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions